Salvatore Piano

🩺 The Liveraim Padua team joined #DiSaluteWeekend 💙

✅Free elastography for the community
✅Awareness on chronic liver disease prevention

👉 Prevention saves lives!
#LiverHealth #Prevention #PublicHealth
@ihieurope.bsky.social @easlnews.bsky.social @unipd.bsky.social

💥A simple & reliable #POCUS method to assess #sarcopenia in #cirrhosis - now in @jhep-reports.bsky.social

✅ Accurate vs CT
⚡️ Fast (1-min test)
💵 Low-cost
🎯 Linked to clinical outcomes 🏥

www.sciencedirect.com/science/arti...

📣New 📰 on recompensation in @jhepatology.bsky.social

✅Only 7% of meet strict Baveno VII criteria
✅Expanded criteria capture ~38% with similar low mortality risk

Recompensation:
⬇️systemic inflammation🔥
👍 improve haemodynamic
⬆️improved survival

doi.org/10.1016/j.jh...

🌎Did you know 1 in 3 adults worldwide has #MASLD?
It’s tied to obesity, diabetes & high cholesterol, it can lead to fibrosis and cancer.
This #WorldLiverDay remember: #FoodIsMedicine!
💪Let's make #liverhealth a priority
@easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social

Early diagnosis of Chronic Liver Disease - What does it means for patients? YouTube video by LIVERAIM

❓Did you miss the second #LIVERAIM webinar?

Check out our Youtube channel and discover what an #earlydiagnosis of #chronicliverdisease truly means for patients!

🎥 www.youtube.com/watch?v=jmw5...

@easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social

New research - Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study

buff.ly/qFR1yau

#LiverSky #MedSky

Huge collective effort from International Club of Ascites

🙏🏻 Thank you @easlnews.bsky.social for supporting this project

Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study This study found important regional differences in AKI severity, phenotype, management, and outcomes in patients with decompensated cirrhosis. Health-care coverage remains an important driver of survi...

📣 ICA GLOBAL AKI study published in @lancetgastrohep.bsky.social

🗺️3,821 patients with cirrhosis
✅38% had AKI
⚠️discrepancies in AKI management and outcomes
⚠️ AKI ➡️22.9% 28-day mortality

🎯Need for equitable & standardized care

www.thelancet.com/journals/lan...

🚀LIVERAIM is on the move!
Biomarker analysis for early liver fibrosis detection has started at #CORELAB of @hospitalclinic.bsky.social on 22k+ serum samples from general and high-risk populations.
🔎Watch how science is shaping the future!
@ihieurope.bsky.social @easlnews.bsky.social

Happy Holidays from the LIVERAIM team!

@easlnews.bsky.social @salvatore-piano.bsky.social @aleksanderkrag.bsky.social

#liversky #medsky